Highline Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-75
Closed -$3.22K – 1468
2026
Q2
$3.22K Hold
75
– – ﹤0.01% 989
2026
Q1
$2.89K Buy
+75
New +$3.09K ﹤0.01% 917

Other funds holding BME

Highline Wealth Partners's BME Position: Q3 2026 in Review

Highline Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q3 2026, closing a stake of 75 shares — an estimated $3.22K sold.

Highline Wealth Partners first reported a position in BME in Q1 2026 and held it in 2 quarters. The position peaked at $3.22K in Q2 2026. 21 funds tracked by Wall St. Rank hold BME as of Q3 2026.

  • Highline Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q3 2026 after selling out during the quarter.
  • Highline Wealth Partners sold 75 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $3.22K.
  • Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q1 2026 and held it in 2 quarters.
  • Highline Wealth Partners's BlackRock Health Sciences Trust position peaked at $3.22K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.